BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26065152)

  • 1. Bullous erythema nodosum leprosum manifesting in the post partum period with unusual features.
    Verma R; Vasudevan B; Pragasam V; Moorchung N; Mitra D; Gopal M
    Lepr Rev; 2015 Mar; 86(1):96-101. PubMed ID: 26065152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bullous erythema nodosum leprosum. A case report in French Guiana].
    CouppiƩ P; Sainte-Marie D; About V; Heid E; Pradinaud R
    Ann Dermatol Venereol; 1998 Mar; 125(3):188-90. PubMed ID: 9747246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lepromatous leprosy in Saudi female from central region.
    al-Majed S
    J Hyg Epidemiol Microbiol Immunol; 1991; 35(2):163-6. PubMed ID: 1940331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rifampicin-induced erythema nodosum leprosum-like eruption in borderline lepromatous leprosy.
    Karthikeyan K; Thappa DM; Kadhiravan T
    Indian J Lepr; 2001; 73(2):167-9. PubMed ID: 11579653
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of rhuIFN-gamma treatment in multibacillary leprosy patients.
    Sampaio EP; Malta AM; Sarno EN; Kaplan G
    Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):268-73. PubMed ID: 8862260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Erythema nodosum leprosum case series report: clinical profile, immunological basis and treatment implemented in health services].
    Guerra JG; Penna GO; Castro LC; Martelli CM; Stefani MM; Costa MB
    Rev Soc Bras Med Trop; 2004; 37(5):384-90. PubMed ID: 15361954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of erythema nodosum leprosum using thalidomide].
    Sheskin J
    Acta Leprol; 1983; 1(1):41-50. PubMed ID: 6401140
    [No Abstract]   [Full Text] [Related]  

  • 8. [Study of erythema nodosum leprosum].
    Nguyen VU
    Ann Dermatol Venereol; 1994; 121(2):194-6. PubMed ID: 7979039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.
    Becx-Bleumink M; Berhe D
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):173-84. PubMed ID: 1522359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deep vein thrombosis: a rare complication of thalidomide therapy in recurrent erythema nodosum leprosum.
    Sharma NL; Sharma V; Shanker V; Mahajan VK; Sarin S
    Int J Lepr Other Mycobact Dis; 2004 Dec; 72(4):483-5. PubMed ID: 15755204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bullous erythema nodosum leprosum: a case report from Nepal.
    Rijal A; Agrawal S; Agarwalla A; Lakhey M
    Lepr Rev; 2004 Jun; 75(2):177-80. PubMed ID: 15282970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pentoxifylline in the treatment of erythema nodosum leprosum: results of an open study].
    de Carsalade GY; Achirafi A; Flageul B
    Acta Leprol; 2003; 12(3):117-22. PubMed ID: 15040702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does thalidomide have a role in leprosy?
    Crawford CL
    Lancet; 2004 Jun; 363(9424):1911. PubMed ID: 15183644
    [No Abstract]   [Full Text] [Related]  

  • 14. Thalidomide in the treatment of leprosy.
    Teo S; Resztak KE; Scheffler MA; Kook KA; Zeldis JB; Stirling DI; Thomas SD
    Microbes Infect; 2002 Sep; 4(11):1193-202. PubMed ID: 12361920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chemotherapy-induced erythema nodosum leprosum: successful treatment with thalidomide].
    Petering H; Kiehl P; Vogelbruch M; Sticht-Groh V; Kapp A; Werfel T
    Hautarzt; 2001 Oct; 52(10 Pt 2):966-9. PubMed ID: 11715395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgG antibody subclasses, tumor necrosis factor and IFN-gamma levels in patients with type II lepra reaction on thalidomide treatment.
    Partida-Sanchez S; Favila-Castillo L; Pedraza-Sanchez S; Gomez-Melgar M; Saul A; Estrada-Parra S; Estrada-Garcia I
    Int Arch Allergy Immunol; 1998 May; 116(1):60-6. PubMed ID: 9623511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Borderline lepromatous leprosy presenting as a single cutaneous plaque.
    Armour KS; Scolyer RA; Barnetson RS
    Australas J Dermatol; 2005 Aug; 46(3):181-3. PubMed ID: 16008652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thalidomide in erythema nodosum leprosum.
    Jew LJ; Middleton RK
    DICP; 1990 May; 24(5):482-3. PubMed ID: 2188435
    [No Abstract]   [Full Text] [Related]  

  • 20. Thalidomide in erythema nodosum leprosum (ENL).
    Bourdillon C
    Lepr Rev; 1988 Jun; 59(2):184-5. PubMed ID: 3246930
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.